Evidence map›Paper›PMID 37602945›Full record

ArticleThe Journal of school health2023

Understanding COVID-19 Vaccine Hesitancy Among K-12 Staff, Parents, and Students: District of Columbia, February to April, 2022.

Miguella Mark-Carew, André van Zyl, Kathleen M Tatti, Muhling Chong, Charles Rose, Katlynn Sifre, Daniel Jarris, William Still, Getahun Aynalem, Michael Welton and 3 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of school health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Miguella Mark-CarewGlobal Government Solutions (G2S) Corporation, 12500 San Pedro Avenue, Suite 403 San Antonio, TX 78216; US Centers for Disease Control and Prevention COVID-19 Emergency Response Team 1600 Clifton Road, Atlanta, GA, 30329.ORCID 0000-0001-9655-9703
André van Zyl4ES Corporation, 5210 Roble Grande Suite 101, San Antonio, TX 78261; US Centers for Disease Control and Prevention COVID-19 Emergency Response Team, 1600 Clifton Road, Atlanta, GA 30329, 5210 Roble Grande Suite 101, San Antonio, TX, 78261.ORCID 0000-0001-6872-5276
Kathleen M TattiGlobal Government Solutions (G2S) Corporation, 12500 San Pedro Avenue, Suite 403 San Antonio, TX 78216; US Centers for Disease Control and Prevention COVID-19 Emergency Response Team 1600 Clifton Road, Atlanta, GA, 30329.ORCID 0000-0001-9414-7887
Muhling ChongGlobal Government Solutions (G2S) Corporation, 12500 San Pedro Avenue, Suite 403 San Antonio, TX 78216; US Centers for Disease Control and Prevention COVID-19 Emergency Response Team 1600 Clifton Road, Atlanta, GA, 30329.ORCID 0009-0001-4239-1332
Charles RoseUS Centers for Disease Control and Prevention COVID-19 Emergency Response Team, 1600 Clifton Road, Atlanta, GA, 30329.ORCID 0000-0003-2359-8060
Katlynn SifreGlobal Government Solutions (G2S) Corporation, 12500 San Pedro Avenue, Suite 403 San Antonio, TX 78216; US Centers for Disease Control and Prevention COVID-19 Emergency Response Team 1600 Clifton Road, Atlanta, GA 30329, 12500 San Pedro Ave, Suite 403, San Antonio, TX, 78216.
Daniel JarrisDistrict of Columbia Department of Health, Washington, DC.
William StillDistrict of Columbia Department of Health, Washington, DC.ORCID 0000-0003-1085-9903
Getahun AynalemGlobal Government Solutions (G2S) Corporation, 12500 San Pedro Avenue, Suite 403 San Antonio, TX 78216; US Centers for Disease Control and Prevention COVID-19 Emergency Response Team 1600 Clifton Road, Atlanta, GA, 30329.ORCID 0000-0002-1340-3701
Michael WeltonGlobal Government Solutions (G2S) Corporation, 12500 San Pedro Avenue, Suite 403 San Antonio, TX 78216; US Centers for Disease Control and Prevention COVID-19 Emergency Response Team 1600 Clifton Road, Atlanta, GA, 30329.ORCID 0000-0001-6097-2010
Ebony S ThomasUS Centers for Disease Control and Prevention COVID-19 Emergency Response Team, 1600 Clifton Road, Atlanta, GA, 30329.ORCID 0000-0002-7966-1316
LaShonda HallUS Centers for Disease Control and Prevention COVID-19 Emergency Response Team, 1600 Clifton Road, Atlanta, GA, 30329.ORCID 0000-0002-1769-9888
Marsha E SamsonDistrict of Columbia Department of Health, Washington, DC.
Centers for Disease Control and Prevention · USDistrict of Columbia Department of Health · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

objectiveDespite widespread availability of COVID-19 vaccines, millions of Americans have not received the recommended vaccine doses. In the District of Columbia (DC), COVID-19 vaccination rates are lowest among residents who are Non-Hispanic (NH) Black and among school-aged children. We assessed COVID-19 vaccine hesitancy among staff and parents of students in DC K-12 public and public charter schools.

methodsWe conducted a telephone-based survey from February 6 to April 16, 2022 to staff, students, and parents of students who participated in school-based COVID-19 screening testing. COVID-19-related survey items included: vaccination status, reasons for not getting vaccinated, perceived vaccine access, and trusted COVID-19 information sources. Utilizing time-to-event analyses, we evaluated differences across demographic groups.

resultsThe interview response rate was 25.8% (308/1193). Most unvaccinated participants were NH Black and ages 5 to 11 years. Median time from vaccine eligibility to uptake was 236 days for NH Black participants vs. 10 days for NH White participants. Vaccine safety was the top concern among unvaccinated participants. Government and healthcare providers were the most trusted COVID-19 information sources.

conclusionsDifferences in timing of vaccine uptake among respondents and greater vaccine hesitancy among NH Black participants compared to other racial/ethnic groups highlight a need for continued tailored outreach and communication using trusted sources to convey the importance, benefits, and safety of COVID-19 vaccination.

Indexed as

COVID-19COVID-19 VaccinesChildDistrict of ColumbiaHumansParentsStudentsVaccinationCOVID-19 VaccinesCOVID-19District of ColumbiaK-12 schoolsracial/ethnicity disparitiestime-to-eventvaccine hesitancy

Identifiers

PMID37602945
PMCPMC10833106
OpenAlexW4386019746

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.